“…Clinical evidence also suggests that MOR blockade with naltrexone is effective in some impulse control disorders (Kim et al, 2001;Grant, 2005;Lahti et al, 2010;Grant et al, 2014), promotes abstinence in substance addiction populations (Krystal et al, 2001;Srisurapanont & Jarusuraisin, 2005;Grassi et al, 2007), possibly through the promotion of impulse control (Sanchez-Roige et al, 2015). There is evidence that naltrexone can also ameliorate neural disturbances in addiction (Savulich et al, 2017;Morris et al, 2018), including those related to impulsive choice (Boettiger et al, 2009), pointing to its potential efficacy as a neuromodulator of impulse control. Therefore, evidence of disturbances to prefrontal endogenous opioid functioning, together with the clinical efficacy of naltrexone in treating impulse control and addiction disorders, suggests that this system may be a viable target for relapse prevention, where there are deficits related to impulsivity.…”